French-Korean Career Forum returns, connecting language and careers
The French-Korean Chamber of Commerce and Industry, the third-largest foreign chamber in Korea, announced Wednesday that it will be hosting the 2025 edition of its annual French-Korean Career Forum on May 15 in Seoul.
Organized in collaboration with the Cultural Service of the French Embassy in South Korea, the Korea Chamber of Commerce and Industry and partners such as CCIP and France Alumni, the event highlights the role of the French language in shaping global careers.
Open to students, graduates, job seekers and professionals, the forum offers networking sessions, job-dating opportunities with recruiters and workshops focused on practical skills such as CV writing, interviews and business French expressions.
The forum aims to support those pursuing careers in sectors such as luxury, tourism, trade, education and technology.
Now marking its ninth year, the forum has become a milestone event for French-speaking talent in Korea.
In 2024, it reached a record offline turnout with 29 companies meeting over 600 attendees. Even during its online editions in 2021 and 2022, the event maintained strong engagement.
Sponsored by Accor, Cafes Richard and JCDecaux, the 2025 forum continues to grow as a platform where language meets professional opportunity, reinforcing FKCCI's mission to foster international talent and bilingual careers in Korea.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
11 hours ago
- Korea Herald
President Lee calls on business circles to restore public trust
President Lee Jae-myung called for South Korea's business circles to mitigate public distrust toward them as he held talks with the entrepreneurs at his office on Friday. "I believe South Korea is no longer in a state where sustainable growth is impossible due to unfair competition, privileges to certain entities, or exploitations (of labor)," the president said during his opening speech at the meeting. "But there is still public distrust (toward South Korean businesses) remaining. I think it would be great to tackle that public distrust." Lee also promised to focus on pouring his administration's capacity into reducing red tape for the business circles, while saying the regulations related to fair business practices and public safety should stand. It was the first meeting between Lee and representatives of business lobby groups since he assumed the presidency on June 4. The meeting was attended by Chey Tae-won, chair of the Korea Chamber of Commerce and Industry; Sohn Kyung-shik, chair of the Korea Enterprises Federation; Ryu Jin, chair of the Federation of Korean Industries; Yoon Jin-sik, chair of the Korea International Trade Association; Kim Ki-moon, chairman of the Korea Federation of Small and Medium Enterprises and Choi Jin-shik, chief of the Federation of Middle Market Enterprises of Korea. Also joining the event were heads of several major South Korean conglomerates, including Samsung Electronics Executive Chairman Lee Jae-yong, Hyundai Motor Group Executive Chair Chung Euisun. LG Chair Koo Kwang-mo and Lotte Chair Shin Dong-bin.
Korea Herald
06-06-2025
- Korea Herald
HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
JAVENÉ, France, June 6, 2025 /PRNewswire/ -- On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of the French Republic, HTL Biotechnology confirms its position as a globalleader in the development and production of pharmaceutical-grade biopolymers, by inaugurating a new production unit dedicated to sterile hyaluronic acid at its Javené (Ille-et-Vilaine) site, a true flagship of French biomanufacturing. With over 30 years of expertise in biopolymers, HTL Biotechnology is reaffirming its commitment through this new production unit to the development of innovative therapeutic solutions for the medicine of today and tomorrow. The manufacture of sterile hyaluronic acid opens the way to new therapeutic opportunites . This cutting-edge process now makes it possible to combine hyaluronic acid with heat-sensitive active molecules, previously incompatible with traditional heat sterilization methods. Simultaneously, mastery of aseptic processes eliminates any risk of microbial contamination and ensures optimum pharmaceutical quality. This innovation marks a decisive step in the development of new combined formulations, bringing improved clinical benefits for patients in many fields, such as ophthalmology and drug delivery. This €12 million investment, part of HTL Biotechnology's €100 million 2022-2026 strategic plan, pursues two main goals: to explore new opportunities in bioproduction, and to strengthen the company's position as a key player in future applications of hyaluronic acid in healthcare. Production is scheduled to start in 2026, following qualification and validation of the industrial equipment. To guarantee the quality and efficiency of this new production unit, HTL Biotechnology has set up specific in-house training courses to instruct its staff in aseptic procedures and the handling of this new product. Because of the highly technical nature of this product, a team of ten specialists has been trained in the specific skills required for its production ensuring the highest quality standards. François Fournier, CEO of HTL Biotechnology, states: " I'm delighted with the prospects this investment gives us for further innovation in pharmaceutical-grade biopolymers. The breadth and complementarity of our portfolio is unique, and we are proud to be able to serve our customers even better. Thanks to this new unit, promising future applications can be explored, offering innovative solutions for the benefit of patients. I am delighted to be able to count on this new facility, which makes our historic Javené site a true flagship for French bioproduction." As an active member of France Biolead, HTL Biotechnology is proud to take part in the second National Biomanufacturing and Biomedicines Day, which this year enjoys the patronage of French President Emmanuel Macron. The company welcomes this recognition, which underscores the strategic importance of the French biomanufacturing and biomedical industry, at the heart of the challenges facing public health, and France. About HTL HTL Biotechnology is a French biotech company and world leader in the development and responsible biomanufacturing of pharmaceutical-grade biopolymers (Hyaluronic Acid, Polynucleotides and soon recombinant human collagen). These biopolymers are used by healthcare companies to develop treatments in a variety of leading therapeutic areas such as ophthalmology, dermatology, medical aesthetics and rheumatology. HTL Biotechnology recently strengthened its position as world leader in the development of pharmaceutical-grade biopolymers by acquiring, through its subsidiary HTL Biotechnology Innovation Inc. (HTL BII - New Jersey), a recombinant protein platform whose most advanced product is recombinant human collagen type III (rhCOL3) at a world-class scientific research center. To meet the world's growing need for biopolymers, the company also has subsidiaries in Asia and is building a neuromodulator production unit in the United States (HTL BMI - Massachusetts). Historically based in Javené (Brittany - France), the company brings together production, innovation, R&D , as well as quality activities on its site. HTL Biotechnology employs nearly 300 people worldwide. Press contact
Korea Herald
06-06-2025
- Korea Herald
Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs
QINGDAO, China, June 6, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, continues to reinforce its leadership in premium display technology. According to Omdia's Q1 2025 data, Hisense ranked No.1 worldwide by volume share in 100-inch and over TVs, MiniLED TVs, and Laser TVs. Hisense led the 100-inch and over TV market with a 56.7% global volume share, ranking No. 1 in 2023, 2024, and Q1 2025. In MiniLED TVs, Hisense rose to the top with a 29.3% global volume share, reflecting rapid growth and consumer trust in its backlight innovations. Hisense also retained its lead in the Laser TV market, with a commanding 69.6% global volume share, continuing its global dominance after ranking No.1 for consecutive six years, based on Omdia data. This strong performance reflects Hisense's long-term commitment to large-screen innovation, AI-powered imaging, and immersive audio-visual experiences. Hisense was the first brand globally announced as an official partner of the FIFA Club World Cup 2025™, demonstrating its forward-looking strategy and growing international influence. Building on this milestone, Hisense launched its global campaign "Own the Moment", cementing its global leadership and connecting cutting-edge technology with the passion of sports fans worldwide. The campaign reflects Hisense's commitment to empowering unforgettable sports moments with premium technology — allowing fans to see, feel, and own the excitement like never before. Hisense has also partnered with French audio expert Devialet to enhance sound performance across its latest products, delivering a richer and more immersive home entertainment experience. These audio enhancements will be available via software update, with availability depending on specific models and regions. With a commitment to technological excellence and user value, Hisense is well-positioned to maintain its momentum in 2025 and beyond. About Hisense Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 160 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 2 worldwide in total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2025Q1). As the first official partner of the FIFA Club World Cup 2025™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide.
